Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for transcatheter aortic valve ...
THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in transfemoral TAVR, with notable differences in specific clinical measures. This ...
Objective To assess the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with medical management in patients with severe aortic stenosis who are ineligible ... with both ...
Self-expanding valves (SEVs) are associated with less prosthesis-patient mismatch (PPM) in East Asian patients with small aortic annuli (SAA) undergoing TAVR, compared with balloon-expandable valves ...
ELEVATED lipoprotein(a) (Lp[a]) levels do not significantly influence aortic valve calcification or mortality in patients undergoing transcatheter aortic valve replacement (TAVR), new research has ...
With its potential to improve clinical outcomes for a broader range of patients, the JenaValve Trilogy System underscores the growing adaptability of TAVR technology in treating complex heart ...
while 100,000 patients die annually due to lack of treatment. Although TAVR market growth has slowed, the analyst sees the market as underpenetrated and views it as a promising target for the next ...
A new memoir by the tech mogul recounts a boyhood steeped in old-fashioned, analog pastimes as well as precocious feats of coding. By Jennifer Szalai It’s among the more playful matters on his ...
Patients from Australia, the United States, and the United Kingdom represent a significant portion of Dentzz’s clientele. Reviews highlight that complex procedures, such as dental implants or ...
Patient Safety National Ratings, Why it Matters Katie Grimm, RN, BSN, MBA Chief Nursing Officer, Northern Nevada Medical Center Northern Nevada Medical Center was recently awarded an “A ...